Miraculins to Distribute Device in China through Cachet Pharma

Miraculins, a Canadian diagnostics company, finalized an agreement for China distribution of its Scout DS® Non-Invasive Diabetes Screening Device. The device will be imported by Catalyn Medical Technologies Limited, a privately-owned Hong Kong company, and distributed by Cachet Pharma (SHE: 002462) of China. Cachet agreed to buy $90 million of the device over the five-year life of the contract. Miraculins will be responsible for obtaining CFDA approval of the device. More details.... Stock Symbol: (TVE: MOM) Share this with colleagues: // //